A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk

被引：0
|
作者：
Eng-Siew Koh
Tu Huan Tran
Mostafa Heydarian
Rainer K Sachs
Richard W Tsang
David J Brenner
Melania Pintilie
Tony Xu
June Chung
Narinder Paul
David C Hodgson
机构：
[1] Princess Margaret Hospital,University of Toronto, Department of Radiation Oncology
[2] Princess Margaret Hospital,University of Toronto, Department of Radiation Physics
[3] University of California,Department of Mathematics
[4] Columbia University Medical Center,Center for Radiological Research
[5] Princess Margaret Hospital,Department of Clinical Study Coordination and Biostatistics
[6] Princess Margaret Hospital,University of Toronto, Department of Medical Imaging
来源：
Radiation Oncology | / 2卷
关键词：
Clinical Target Volume; Dose Volume Histogram; Secondary Cancer; Excess Relative Risk; Atomic Bomb Survivor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Does "Involved-Field"-Radiotherapy improve survival for children with Hodgkin's lymphoma in complete remission after chemotherapy?
    Reinartz, G.
    Eich, H. T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (04) : 344 - 345
  • [22] High dose chemotherapy and stem cell rescue for aggressive non-Hodgkin's lymphoma: Pattern of failure and implications for involved-field radiotherapy
    Mundt, AJ
    Williams, SF
    Hallahan, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (03): : 617 - 625
  • [23] Conventional or 3D irradiation planning of involved-field radiotherapy in Hodgkin's lymphoma in the scope of the DHSG studies
    Hansemann, K.
    Eich, H. T.
    Hilger, T.
    Mueller, R.-P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 62 - 63
  • [24] Second cancer risk assessments after involved-site radiotherapy for mediastinal Hodgkin lymphoma
    Mazonakis, Michalis
    Lyraraki, Efrossyni
    Damilakis, John
    MEDICAL PHYSICS, 2017, 44 (07) : 3866 - 3874
  • [25] A Comparison of Involved Field vs. Involved Node Radiation Therapy in the Pediatric Hodgkin Lymphoma Population: Reduction in Second Malignancy Risk
    Ballas, L.
    Wolden, S. L.
    Shuryak, I.
    Shah, J. N.
    Balmir, B.
    Chao, K. S.
    Brenner, D. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S514 - S514
  • [26] Involved-field radiotherapy (IFRT) and involved-nodal radiotherapy (INRT) as a component of combination therapy for limited stage Hodgkin lymphoma: a question of field size
    Campbell, B.
    Voss, N.
    Pickles, T.
    Morris, J.
    Connors, J. M.
    EJC SUPPLEMENTS, 2007, 5 (04): : 345 - 346
  • [27] RISK OF CARDIAC AND VALVULAR DISEASE AFTER MANTLE OR INVOLVED NODE RADIOTHERAPY IN HODGKIN LYMPHOMA
    Maraldo, M.
    Aznar, M.
    Brodin, P.
    Af Rosenschold, P. Munck
    Petersen, P. M.
    Vogelius, I. R.
    Specht, L.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S349 - S349
  • [28] The Impact of Involved Node, Involved Field and Mantle Field Radiotherapy on Estimated Radiation Doses and Risk of Late Effects for Pediatric Patients with Hodgkin Lymphoma
    Maraldo, M. V.
    Jorgensen, M.
    Brodin, N. P.
    Aznar, M. C.
    Vogelius, I. R.
    Petersen, P. M.
    Berthelsen, A. K.
    Christensen, C. B.
    Hjalgrim, L. L.
    Specht, L.
    PEDIATRIC BLOOD & CANCER, 2014, 61 (04) : 717 - 722
  • [29] Quality control of involved-field radiotherapy in patients with advanced stage Hodgkin's lymphoma (HL) enrolled on the EORTC trial 20884
    Aleman, BMP
    Girinsky, T
    Strijk, S
    Van der Maazen, RWM
    Bortolus, R
    Meijnders, P
    Pinna, A
    Henry-Amar, M
    Raemaekers, JMM
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S205 - S206
  • [30] A Comparison of Involved-Field Radiation Therapy Treatment Outcomes in Pediatric and Young Adult Hodgkin Lymphoma
    Huynh-Le, M.
    Walker, A.
    Wharam, M.
    Priel, I. Paz
    Terezakis, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S600 - S601
12345